Skip to main content
OpenTrials

Clinical trial condition

Adult Anaplastic Oligodendroglioma

Explore clinical trials studying Adult Anaplastic Oligodendroglioma. Study availability and eligibility vary by location and protocol.

20 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Adult Anaplastic Oligodendroglioma trial results

Completed

Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma

NCT00823797

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +22 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

FR901228 in Treating Patients With Recurrent High-Grade Gliomas

NCT00085540

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +21 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide

NCT00369590

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +21 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details
Completed

Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma

NCT00112736

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma, +27 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma

NCT00093613

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +21 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Adult Brain Tumor Consortium Baltimore, Maryland, United States
View Trial Details
Completed

Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma

NCT00650923

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +23 more
Locations
  • University of California at Los Angeles (UCLA ) Los Angeles, California, United States
  • UCSF-Mount Zion San Francisco, California, United States
  • University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
  • Adult Brain Tumor Consortium Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas

NCT00268385

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +23 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 17 locations
View Trial Details

Related conditions